SynapDx Corporation, a diagnostic company developing an innovative blood test for the early detection of autism spectrum disorders, today announced that Kevin Hrusovsky has been appointed to its Board of Directors. Hrusovsky, former president of Life Sciences and Technology at PerkinElmer, has a breadth of experience in launching technologies and building fast-growing companies in the life science industry.
Help employers find you! Check out all the jobs and post your resume.
